PATENT CLAIM ANALYSIS

Application Number: 15883100
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["530", "324000"]

Abstract:
The current invention discloses methods to modify protein and peptide and antigen to treat disease such as pathogen infection, autoimmune diseases and cancer. The method involves increasing the molecular weight of the protein by connecting multiple peptide units with site specific conjugation to extend the in vivo half life. The current invention also discloses methods to construct activatable enzyme, which becomes active when they reach the treatment target, therefore provide higher specificity for treatment. The current invention also relates to methods to treat disease with hemopurification.

Claim (Index 6):
The device of  claim 1  further comprising adsorbent that can remove endotoxin.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 86.0
- Lexical Diversity: 1.52459
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15124058', '12759801', '12228859', '15232714', '14997827']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5963136357475237
- 35 USC 102 Novelty (BERT): 0.5142001690575357
- Combined Prediction Score: 0.5881022890785249
- Mean Citation Score: 179.019792
- Max Citation Score: 186.83347
- Similarity Product: 90.52472887643422

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test